Peanut Allergy Treatment Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
Peanut allergy (PA) stands out from other food allergies due to its higher prevalence of accidental exposure, severe responses, and potentially lethal anaphylaxis. Approximately 7%-14% of PA patients experience accidental peanut exposure each year, with one-third to one-half potentially facing anaphylaxis, although fatalities are rare. These risks result in significantly higher healthcare utilization and economic expenditures for people with PA, as well as limitations on their everyday activities.
Peanut Allergy Treatment Market Regional AnalysisCHAPTER 1. Industry Overview of Peanut Allergy Treatment Market
1.1. Definition and Scope
1.1.1. Definition of Peanut Allergy Treatment
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Peanut Allergy Treatment Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Peanut Allergy Treatment Market By Drug Class
1.2.3. Peanut Allergy Treatment Market By Route Of Administration
1.2.4. Peanut Allergy Treatment Market By Distribution Channel
1.2.5. Peanut Allergy Treatment Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Peanut Allergy Treatment Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Peanut Allergy Treatment Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Peanut Allergy Treatment Market By Drug Class
5.1. Introduction
5.2. Peanut Allergy Treatment Revenue By Drug Class
5.2.1. Peanut Allergy Treatment Revenue (USD Million) and Forecast, By Drug Class, 2020-2032
5.2.2. Antihistamines
5.2.2.1. Antihistamines Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Immunotherapies
5.2.3.1. Immunotherapies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Epinephrine
5.2.4.1. Epinephrine Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Others
5.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Peanut Allergy Treatment Market By Route Of Administration
6.1. Introduction
6.2. Peanut Allergy Treatment Revenue By Route Of Administration
6.2.1. Peanut Allergy Treatment Revenue (USD Million) and Forecast, By Route Of Administration, 2020-2032
6.2.2. Injectable
6.2.2.1. Injectable Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Oral
6.2.3.1. Oral Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Others
6.2.4.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Peanut Allergy Treatment Market By Distribution Channel
7.1. Introduction
7.2. Peanut Allergy Treatment Revenue By Distribution Channel
7.2.1. Peanut Allergy Treatment Revenue (USD Million) and Forecast, By Distribution Channel, 2020-2032
7.2.2. Retail Pharmacy
7.2.2.1. Retail Pharmacy Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Hospital Pharmacy
7.2.3.1. Hospital Pharmacy Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Others
7.2.4.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Peanut Allergy Treatment Market By Country
8.1. North America Peanut Allergy Treatment Market Overview
8.2. U.S.
8.2.1. U.S. Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
8.2.2. U.S. Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
8.2.3. U.S. Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
8.3. Canada
8.3.1. Canada Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
8.3.2. Canada Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
8.3.3. Canada Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Peanut Allergy Treatment Market By Country
9.1. Europe Peanut Allergy Treatment Market Overview
9.2. U.K.
9.2.1. U.K. Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
9.2.2. U.K. Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
9.2.3. U.K. Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.3. Germany
9.3.1. Germany Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
9.3.2. Germany Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
9.3.3. Germany Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.4. France
9.4.1. France Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
9.4.2. France Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
9.4.3. France Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.5. Spain
9.5.1. Spain Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
9.5.2. Spain Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
9.5.3. Spain Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
9.6.2. Rest of Europe Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
9.6.3. Rest of Europe Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Peanut Allergy Treatment Market By Country
10.1. Asia Pacific Peanut Allergy Treatment Market Overview
10.2. China
10.2.1. China Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
10.2.2. China Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
10.2.3. China Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.3. Japan
10.3.1. Japan Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
10.3.2. Japan Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
10.3.3. Japan Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.4. India
10.4.1. India Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
10.4.2. India Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
10.4.3. India Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.5. Australia
10.5.1. Australia Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
10.5.2. Australia Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
10.5.3. Australia Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.6. South Korea
10.6.1. South Korea Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
10.6.2. South Korea Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
10.6.3. South Korea Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
10.7.2. Rest of Asia-Pacific Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
10.7.3. Rest of Asia-Pacific Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Peanut Allergy Treatment Market By Country
11.1. Latin AmericaPeanut Allergy Treatment Market Overview
11.2. Brazil
11.2.1. Brazil Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
11.2.2. Brazil Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
11.2.3. Brazil Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.3. Mexico
11.3.1. Mexico Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
11.3.2. Mexico Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
11.3.3. Mexico Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
11.4.2. Rest of Latin America Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
11.4.3. Rest of Latin America Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Peanut Allergy Treatment Market By Country
12.1. Middle East & Africa Peanut Allergy Treatment Market Overview
12.2. GCC
12.2.1. GCC Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
12.2.2. GCC Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
12.2.3. GCC Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.3. South Africa
12.3.1. South Africa Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
12.3.2. South Africa Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
12.3.3. South Africa Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Peanut Allergy Treatment Revenue (USD Million) and Forecast By Drug Class, 2020-2032
12.4.2. Rest of Middle East & Africa Peanut Allergy Treatment Revenue (USD Million) and Forecast By Route Of Administration, 2020-2032
12.4.3. Rest of Middle East & Africa Peanut Allergy Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Peanut Allergy Treatment Market
13.1. Peanut Allergy Treatment Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Peanut Allergy Treatment Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Aimmune Therapeutics Inc.
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Million), 2022
14.1.3.2. Aimmune Therapeutics Inc. 2022 Peanut Allergy Treatment Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Sanofi
14.3. Aravax Pty Ltd
14.4. Regeneron Pharmaceuticals Inc.
14.5. Alladapt Immunotherapeutics, Inc.
14.6. DBV Technologies
14.7. Prota Therapeutics
14.8. Vedanta Biosciences, Inc.
14.9. Teva Pharmaceuticals Industries Ltd.
Frequently Asked Questions
How big is the peanut allergy treatment market?
The peanut allergy treatment market size was USD 437 Million in 2022.
What is the CAGR of the global peanut allergy treatment market from 2023 to 2032?
The CAGR of peanut allergy treatment is 11.5% during the analysis period of 2023 to 2032.
Which are the key players in the peanut allergy treatment market?
The key players operating in the global market are including Aimmune Therapeutics Inc., Sanofi, Aravax Pty Ltd, Regeneron Pharmaceuticals Inc., Alladapt Immunotherapeutics, Inc., DBV Technologies, Prota Therapeutics, Vedanta Biosciences, Inc., and Teva Pharmaceuticals Industries Ltd.
Which region dominated the global peanut allergy treatment market share?
North America held the dominating position in peanut allergy treatment industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of peanut allergy treatment during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global peanut allergy treatment industry?
The current trends and dynamics in the peanut allergy treatment industry include increasing prevalence of peanut allergies, growing awareness and diagnosis of peanut allergies, and advancements in peanut allergy immunotherapy.
Which route of administration held the maximum share in 2022?
The injectable route of administration held the maximum share of the peanut allergy treatment industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
